Paramjeet Kaur

Title: Paramjeet Kaur: Innovator in Anticonvulsive Pharmaceutical Composition

Introduction

Paramjeet Kaur is a notable inventor based in Parsippany, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for medical use. His work focuses on enhancing the delivery and effectiveness of anticonvulsive medications.

Latest Patents

Paramjeet Kaur holds a patent for a transnasal anticonvulsive pharmaceutical composition. This invention comprises diazepam as an active ingredient, along with water, a fatty acid ester, diethylene glycol monoethyl ether, ethanol, and sodium glycocholate. The formulation is designed to improve diazepam solubility and transmucosal permeability while minimizing the content of water and ethanol. This innovative approach allows for effective treatment of convulsions through transnasal administration.

Career Highlights

Throughout his career, Paramjeet Kaur has worked with prominent companies in the pharmaceutical industry, including SK Holdings Co., Ltd. and SK Biopharmaceuticals Co., Ltd. His experience in these organizations has contributed to his expertise in developing advanced pharmaceutical solutions.

Collaborations

Paramjeet has collaborated with notable professionals in his field, including Kwon Ho Kim and Jae Hoon Jo. These partnerships have facilitated the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Paramjeet Kaur's innovative work in the field of anticonvulsive pharmaceutical compositions showcases his dedication to improving medical treatments. His contributions are significant in enhancing the effectiveness of medications for patients in need.